> Products > 875712-88-2

China 875712-88-2 Factory

We have been also specializing in improving the things administration and QC system to ensure that we could preserve terrific gain within the fiercely-competitive company for 875712-88-2,CAS NO 875712-88-2,Delafloxcain intermediate,Delafloxcain advance intermediate,benzenepropanoic acid, α-[[(6-amino-3,5-difluoro, We welcome new and old customers to contact us by phone or send us inquiries by mail for future business relationships and achieving mutual success.
875712-88-2, Our company always provides good quality and reasonable price for our customers. In our efforts, we already have many shops in Guangzhou and our solutions have won praise from customers worldwide. Our mission has always been simple: To delight our customers with best quality hair solutions and deliver on time. Welcome new and old customers to contact us for the future long term business relationships.

Hot Products

1,2-Piperidinedicarboxylic acid, 5-hydroxy-, 1-(1,1-diMethylethyl) ester, (2S,5S)
Product Name:1,2-Piperidinedicarboxylic acid, 5-hydroxy-, 1-(1,1-diMethylethyl) ester, (2S,5S)
Molecular Formula:C11H19NO5
Molecular Weight:245.27
CAS Registry Number:1487347-86-3
3-CHLORO-2,4-DIFLUORONITROBENZENE
Product Name:3-CHLORO-2,4-DIFLUORONITROBENZENE
Molecular Formula:C6H2ClF2NO2
Molecular Weight:193.54
CAS Registry Number:3847-58-3
Tiamulin
Product Name:Tiamulin
Molecular Formula:C28H47NO4S
Molecular Weight;493.74
CAS Registry Number;55297-95-5
(2R,4S)-5-((1,1'-Biphenyl)-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid
Product Name:(2R,4S)-5-((1,1'-Biphenyl)-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid
Molecular Formula:C23H29NO4
Molecular Weight:383.48
CAS Registry Number:1012341-50-2
(3S,4S)-3-[(R)-1-(tert-Butyldimethylsilyloxy)ethyl]-4- [(R)-1-carboxyethyl]-2-azetidinone
Product Name:(3S,4S)-3-[(R)-1-(tert-Butyldimethylsilyloxy)ethyl]-4- [(R)-1-carboxyethyl]-2-azetidinone
Molecular Formula:C14H27NO4Si
Molecular Weight:301.46
CAS Registry Number:90776-58-2
Eribulin intermediate
Product Name:Eribulin intermediate
Molecular Formula:C21H35IO4
Molecular Weight:478.41
CAS Registry Number:157322-47-9

Related Blog
Reviews

What Is Ursodeoxycholic Acid Used For?
Ursodeoxycholic acid is a cholelithiant commonly used in the gastroenterology department, and also a cholelithiasis dissolving agent, so it can be used in the treatment of gallstones under normal circumstances, on the premise...
Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)
Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.
CAS 148553-50-8 What is Pregabalin?
Pregabalin is an anti-epileptic drug, also called an anticonvulsant. It works by slowing down impulses within the brain that cause seizures. Pregabalin also affects chemicals within the brain that send pain signals across the systema nervosum.
Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS
Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...
Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?
API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.
FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC
On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Related Search

CAS NO 875712-88-2

China 875712-88-2 Factory

Related Products

Hot Products

1,2-Piperidinedicarboxylic acid, 5-hydroxy-, 1-(1,1-diMethylethyl) ester, (2S,5S)

3-CHLORO-2,4-DIFLUORONITROBENZENE

Tiamulin

(2R,4S)-5-((1,1'-Biphenyl)-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid

(3S,4S)-3-[(R)-1-(tert-Butyldimethylsilyloxy)ethyl]-4- [(R)-1-carboxyethyl]-2-azetidinone

Eribulin intermediate

What Is Ursodeoxycholic Acid Used For?

Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

CAS 148553-50-8 What is Pregabalin?

Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

Annabelle 2023-02-07 15:22:20

Marcie Green 2022-04-02 01:09:34

Constance 2023-10-09 22:44:30

Johnny 2023-01-11 08:02:18

Alberta 2022-05-21 06:55:11

Lydia 2023-01-30 20:08:26

Related Search

Send Inquiry